Ilknur Icke
Director, Digital Science
Novo Nordisk
Tom Wimbiscus
Shareholder
McAndrews
Edward Angelini
Associate General Counsel
Amneal Pharmaceuticals
Yves Fomekong Nanfack
PhD, Executive Director, Head, End to End AI Foundations, Large Molecules Research
Sanofi
Learn how to transform raw data into actionable insights through effective data strategy, integration, and governance to fuel AI innovation in pharma.
Rameez Chatni
Global Director, AI Solutions, Pharmaceutical & Life Sciences
Cloudera
Cloudera
Website: https://www.cloudera.com/
Cloudera is a hybrid platform for data, analytics, and AI. With 100x more data under management than other cloud-only vendors, Cloudera empowers global enterprises to transform data of all types, on any public or private cloud, into valuable, trusted insights. Our open data lakehouse delivers scalable and secure data management with portable cloud-native analytics, enabling customers to bring GenAI models to their data while maintaining privacy and ensuring responsible, reliable AI deployments. The world’s largest brands in financial services, insurance, media, manufacturing, and government rely on Cloudera to use their data to solve what once seemed impossible—today and in the future.
Alexander Horspool
Associate Director, Innovation, Biotherapeutics Discovery
Boehringer Ingelheim
Wolfgang Colsman
Founder & CEO
ZONTAL
With nearly 30 years of visionary leadership, Wolfgang Colsman serves as the Chief Executive Officer of ZONTAL, a pioneering enterprise platform transforming the way organizations manage and preserve their digital information. Under his leadership, ZONTAL has become a catalyst for change across industries, redefining how data is captured, connected, and safeguarded for long-term value.
Before founding ZONTAL, Wolfgang spent over two decades at OSTHUS as Chief Innovation Officer and Chief Technology Officer, where he guided large-scale digital transformation initiatives. His ability to bridge cutting-edge technology with real-world business needs helped establish OSTHUS as a trusted, vendor-agnostic partner driving innovation for global enterprises.
Beyond his corporate achievements, Wolfgang has left a lasting mark on the life sciences and technology ecosystems through his leadership at the Allotrope Foundation and the Pistoia Alliance Methods Hub project. By championing data standards, interoperability, and collaborative infrastructures, he has empowered industries to break down silos, accelerate discovery, and unlock new opportunities for digital transformation. These efforts continue to shape how organizations think about data as a strategic asset rather than a byproduct.
Recognized for his ability to anticipate technological shifts and inspire collaborative progress, Wolfgang has become a respected voice in the digital landscape—bringing together vision, strategy, and execution to create sustainable impact.
ZONTAL
Website: https://zontal.io/
ZONTAL provides the premier data platform tailored for the life science industry. Our platform is at the forefront of digital transformation, delivering innovative solutions that address the intricate challenges faced by large-scale enterprises. Our services streamline IT processes, facilitate the integration of AI/ML applications, accelerate product time-to-market, and enhance regulatory compliance.
With a global presence encompassing the US, Europe, and Asia, ZONTAL is well positioned to offer seamless support to our clients worldwide. Our network of dedicated integration and service partners enables us to deliver our expertise and solutions in any country and across all time zones, ensuring our customers receive unparalleled support wherever they are.
The idea of a “one-click” Biologics License Application (BLA) has become the ultimate benchmark for what AI could enable in drug development — a world where data moves seamlessly from discovery to submission, with every result, dataset, and citation verified, traceable, and regulator-ready. But how far are we actually from that reality?
This session explores the technologies, infrastructures, and cultural shifts needed to bring automation to one of the most complex and high-stakes processes in life sciences: regulatory submission. The discussion will cut through the hype to define what “submission-grade AI” really means, the challenges that still stand in the way of full automation, and what it will take to build the regulatory trust required to get there.
Join us as we examine the future of AI-driven submissions — and ask the provocative question: could the next BLA really be submitted with a single click?
Moderator
Farouk Daher
Head of Operations
Bluenote
Bluenote
Website: https://www.bluenotehealth.com/
Bluenote helps scientists, researchers, and medical writers accelerate critical workflows by 50–75%—so you can spend less time on paperwork and more time advancing life-saving therapies.
Learn how scalable, cloud-based AI infrastructure accelerates model training, data integration, and collaborative research across global drug discovery teams.
Kevin Cochrane
Chief Marketing Officer
Vultr
Kevin is a 25+ year pioneer of the digital experience space. Now at Vultr, Kevin is now working to build Vultr's global brand presence as a leader in the independent Cloud platform market.
Vultr
Website: https://www.vultr.com/
Vultr, founded in 2014, is on a mission to empower developers and businesses by simplifying the deployment of infrastructure via its advanced cloud platform. Vultr is strategically located in 32 data centers around the globe and provides frictionless provisioning of Cloud Compute, Cloud GPU, Cloud Storage, Networking, and Bare Metal.
Explore practical strategies for building high-quality, diverse datasets that reduce bias and improve model performance across drug discovery pipelines.
Nevin Gerek Ince
Director, Data & Solutions Engineering
Novo Nordisk